Earlier this month, Chief Executive Officer Kenneth Frazier had said the company aims to start human trials on one of its Covid-19 vaccine candidates “fairly soon,” with a second vaccine candidate likely to begin trials later this year.
from Hindustan Times - world https://ift.tt/2RkKKyI
via IFTTT
from Hindustan Times - world https://ift.tt/2RkKKyI
via IFTTT
No comments